2025 Society of Toxicology Annual Meeting and Tox Expo

HESI will attend the 2025 Society of Toxicology Annual Meeting and Tox Expo in Orlando, Florida.

Symposium Session: Navigating Complexity: How ‘Omics in Short-Term Animal Studies Are Optimizing and Accelerating Chemical Risk Assessment
HESI eSTAR Committee Member Speakers: Connie Mitchell (HESI), David Rouquie (Bayer), Richard Currie (Syngenta), Leah Wehmas (EPA), and Florian Caiment (Maastricht University)
Date: Monday, March 17, 2025, 9:15 am - 12:00 pm

Interactive panel: Facing Inconvenient Truths: How the Current Toxicology Research Ecosystem Limits Its Potential for Public and Environmental Health Protection.
Co-chaired by Robyn Tanguay (Oregon State University) and Sandrine Deglin (HESI), this session will bring together a panel of experts from academia, government, industry, and early-career researchers to critically assess systemic challenges in toxicology. All are welcome to come and engage in an open dialogue, share innovative ideas, and help shape actionable strategies to enhance toxicology’s impact on human and environmental health.
Date: Wednesday, March 19, 1:30 pm - 4:15 pm.

Posters:
Botanical Safety Consortium 

• 4069: Poster Board - K568: Prediction of physicochemical and pharmacokinetic properties of botanical constituents by computational models
• 4363: Poster Board - C197: From Neat Compounds to Complex Mixtures: In Vitro Functional Cardiotoxicity Testing of Botanical Extracts
• 4614: Poster Board - J450: Botanical extracts and active constituents dose-dependently modulate neuronal activity in rodent primary cortical cultures measured using microelectrode array (MEA)

Emerging Systems Toxicology for the Assessment of Risk (eSTAR) 

• 3326: Poster Board - J456: Identifying Peroxisome Proliferator-Activated Receptor Alpha (PPARα) independent transcriptome after PFOA exposure
• 3415: Poster Board - J546: Leveraging Cell Painting for cytotoxicity and mode-of-action analysis in primary human hepatocytes
• 4528: Poster Board - G362: Activation of Estrogen Receptor Alpha (ERalpha) by Endocrine Disrupting Chemicals Results in Hepatomegaly in Rat Liver